PVR Inox Ltd Q4 FY2022 Concall Summary

Key Takeaways

• A quarter of two halves, ending on a high: January and February posted operational EBITDA losses due to the Omicron wave and a content drought, but March delivered 20%+ pre-Ind AS EBITDA margins on post-COVID record admissions.
• The content pipeline is back and polarizing sharply: Hits like KGF 2, RRR, and The Kashmir Files are dramatically over-indexing while weaker films struggle, reinforcing that blockbusters drive the business.
• The INOX merger is the defining strategic event: Filed with stock exchanges on 30th March, the deal targets completion by Q4 FY23, though management sidestepped questions on potential CCI intervention and micro-market concentration risk.
• Ad revenue recovery lags the box office rebound: March ad spend was only ~40% of pre-COVID levels, and management expects the journey back to normal to take another 3–4 months as media planners slowly re-prioritize cinema.
• What to watch next quarter: Whether the strong March momentum sustains through a full quarter with a consistent content slate, any regulatory noise on the INOX merger, and the pace of advertising revenue recovery.

The Omicron Quarter: From Losses to a Record March

• Third wave disruption: The Omicron wave hit in the last week of December 2021, peaked mid-January, and receded by end-January, but state-level capacity restrictions and night curfews, plus Delhi and Haryana effectively shutting cinemas, froze the Hindi film release calendar until late February.
• Content vacuum: The blockbuster release cycle that began in November 2021 stopped abruptly when restrictions were announced, leaving January and most of February with no fresh content, which pushed the company into operational EBITDA losses for those two months.
• March turnaround: Content resumed from the fourth week of February with Valimai, Bheemla Nayak, and Gangubai, followed by The Kashmir Files, RRR, and Batman in March, driving admissions to post-COVID highs and delivering EBITDA margins above 20% for the month.
• Profitability drivers: The March margin performance was built on very strong footfalls, controlled costs, strong average ticket price (ATP), and strong spend per head (SPH), with ad spend still a drag at only ~40% of pre-COVID levels.

Gianchandani: "So, our business is of peaks and valleys. There would always be surprises. There would always be films, which will surprise us on the negative side, on the downside and then there would be films, which will beat our most optimistic expectations and surprise us on the upside. That's the nature of our business."

Content & Box Office: Polarization Defines the Recovery

• Hits are hitting harder: The Kashmir Files exceeded wildest expectations, Gangubai did ~Rs. 150–160 cr against an expected Rs. 70–80 cr, KGF 2 became the second-biggest Hindi film all-time after Bahubali 2, and Doctor Strange posted the second-highest opening weekend since reopening.
• The dubbed-film signal: Management highlighted that a dubbed film with a relatively unknown star doing Rs. 400+ crores in Hindi demonstrates the latent potential for a well-made Hindi film rooted in Indian ethos with a popular face.
• Theatrical window normalizing: Hindi films will return to the erstwhile 8-week theatrical window by end of July 2022, while different language films will have different arrangements.
• Distribution sharing back to normal: The accommodation strategy on film hire percentages stopped in March, with sharing percentages returning to historic levels, though the blended film hire rate will vary depending on which language films perform best in a given quarter.
• Distribution business recovery: The distribution segment saw a sharp recovery in FY22, aided by a couple of big theatrical releases and Hollywood foreign-language inventory moving to streaming and television.

The INOX Merger: Execution Timeline Meets Regulatory Silence

• Deal mechanics: Boards of both companies approved the merger on 27th March 2022, and the draft scheme of amalgamation was filed with BSE and NSE on 30th March 2022, with stock exchange and SEBI approval awaited before filing with NCLT.
• Indicative timeline: Management guided a 9-month window: 2–3 months for stock exchange and SEBI approval from the 30th March filing, followed by 6–8 months for the NCLT process, targeting completion by the beginning of Q4 or sometime in Q4 FY23.
• Regulatory stance: Based on counsel advice, the company does not believe the merger requires competition regulatory approval based on thresholds, but management acknowledged that timelines could be impacted if the regulator intervenes.
• Unanswered CCI questions: When pressed on whether the CCI might require screen divestments in micro-markets, as happened in the DT Cinemas case, management called the question hypothetical, stated the two situations are not comparable because the current merger is not notifiable, and declined to discuss any minimum divestment threshold.

Advertising: The Slowest Wheel to Turn

• Structural lag: Cinema is the fourth or fifth priority for media planners, and the medium was off-radar for close to 30 months during the pandemic, so recovery is taking time because media plans are made 3–4 months prior to big launches.
• Regional divergence: Retail recovery is much better, especially in South India, while the West region, which has the maximum corporate business, is taking more time.
• Recovery timeline: Management expects the journey back to pre-COVID ad spend numbers to take another 3–4 months from the May 2022 call date, with big blockbusters needed to drive the bulk of earnings.

Dutta: "You need to understand cinema as a medium is the fourth or the fifth priority for a media planner. So, technically, we have been off radar for close to about 30 odd months and it will take time before planners and typically a plan gets made 3 or 4 months prior to a big launch and that's where most of bulk of our earnings happen."

Operational Levers: Pricing, Costs & Footfalls

• ATP strategy: PVR's ATP improved sequentially while a competitor's declined, which management attributed to a healthier mix between premium and non-premium offerings, content programming, timing, and strong South India performance, not to a price increase.
• No further price hikes planned: Management stated ATP will remain at current levels, with the focus on maximizing footfalls going forward, noting that whatever growth has been taken on ATP is largely on account of inflationary cost increases after being out of business for over two years.
• SPH outperformance: PVR's SPH growth was healthier than competition, with management citing consistent work on this metric.
• Cost structure reset: People cost in Q4 was ₹81 crores, approximately 20% lower than the FY20 quarterly average of ~₹100 crores, and management is reasonably confident of operating on a same-store level with lower headcount than pre-pandemic going forward.
• Closed properties: 23 screens across 9 properties were closed on 31st March where leases had expired, contributing approximately 2% of pre-pandemic revenues.

Dutta: "Technically, we've been out of business for over 2 years. So, whatever growth we have taken on ATP is largely on account of inflationary cost at all ends going up and now that we've been operating at whatever rate we intend not take any pricing up. This is largely going to remain where it is, and we are wanting to maximize footfalls as we go further."

Expansion & Capital Allocation

• FY23 screen pipeline: The company plans to open 120 to 125 screens in FY23, with most becoming operational in the latter half of the year, driven by mall development previously stuck due to lockdowns now coming through and large-format properties (8–10–12 screens) accelerating the screen count.
• Geographic spread: New screens are spread evenly across the country, with South India having more large-format properties because of acceptance of multiple language films; Tier-2 and Tier-3 cities will see additions as retail infrastructure develops.
• CAPEX plan: ₹350 to 400 crores on new built screens plus maintenance CAPEX, funded entirely through internal accruals and available liquidity.
• Leverage peaking: Management believes leverage has ideally peaked and intends to fund all growth through internal accruals, with free cash generation from earnings reducing leverage from current levels; average interest cost is expected to remain around 9% with no material change.
• Oma Cinemas tie-up: A design-concept partnership signed less than 10 days before the call, with no long-term royalty payable and exclusivity for the Indian market; still at an early stage with no location identified and CAPEX per screen not yet determinable.

Sood: "I think our leverage is ideally peaked now and as we get into earnings and cash flow generation from the business, hopefully, it should start coming down from these levels."

Guidance & Commitments

Key Metrics